cutaneous melanoma

MILLBRAE, Calif., August 11, 2026 Eikon Therapeutics announced the selection of a 0.60 mg/m² dose of EIK1001 for patients...

FRIENDSWOOD, Texas, June 25, 2026 Castle Biosciences announced the publication of a prospective multicenter study in Dermatology and Therapy...